AI & ChatGPT searches , social queries for NECITUMUMAB

Search references for NECITUMUMAB. Phrases containing NECITUMUMAB

See searches and references containing NECITUMUMAB!

AI searches containing NECITUMUMAB

NECITUMUMAB

  • Necitumumab

    • Recombinant human monoclonal antibody

    Necitumumab (INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic, which is manufactured by Eli Lilly. It binds to the epidermal

    Necitumumab

    Necitumumab

    Necitumumab

  • Amitriptyline

    • Tricyclic antidepressant

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Avutometinib/defactinib

    • Combination cancer medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Avutometinib/defactinib

    Avutometinib/defactinib

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Growth factor

    Growth_factor

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Wnt signaling pathway

    Wnt_signaling_pathway

  • Pegfilgrastim

    • Monoclonal antibody

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Pegfilgrastim

    Pegfilgrastim

  • Trofinetide

    • Pharmaceutical drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Trofinetide

    Trofinetide

    Trofinetide

  • Fruquintinib

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fruquintinib

    Fruquintinib

    Fruquintinib

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Lapatinib

    • Cancer medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Lapatinib

    Lapatinib

    Lapatinib

  • Testosterone

    • Primary male sex hormone

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Testosterone

    Testosterone

    Testosterone

  • ATC code L01

    • Pharmaceutical drug classification

    Margetuximab L01FD07 Zanidatamab L01FE01 Cetuximab L01FE02 Panitumumab L01FE03 Necitumumab L01FF01 Nivolumab L01FF02 Pembrolizumab L01FF03 Durvalumab L01FF04 Avelumab

    ATC code L01

    ATC_code_L01

  • TGF alpha

    • Protein

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    TGF alpha

    TGF alpha

    TGF_alpha

  • Ramucirumab

    • Pharmaceutical drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Ramucirumab

    Ramucirumab

  • Artemin

    • Protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Artemin

    Artemin

    Artemin

  • IGFBP6

    • Protein-coding gene in the species Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    IGFBP6

    IGFBP6

    IGFBP6

  • IGFBP7

    • Protein-coding gene in the species Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    IGFBP7

    IGFBP7

    IGFBP7

  • FGF7

    • Protein-coding gene in the species Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    FGF7

    FGF7

    FGF7

  • Dexamethasone

    • Corticosteroid medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Ephrin

    • Family of proteins

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Ephrin

    Ephrin

    Ephrin

  • EPH receptor A4

    • Protein-coding gene in the species Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    EPH receptor A4

    EPH receptor A4

    EPH_receptor_A4

  • Insulin-like growth factor 1

    • Protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • PDGFB

    • Protein-coding gene in the species Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    PDGFB

    PDGFB

    PDGFB

  • Elranatamab

    • Medication

    Mirvetuximab soravtansine Mogamulizumab Moxetumomab pasudotox Naxitamab Necitumumab Nivolumab (+hyaluronidase, +relatlimab) Olaratumab Oportuzumab monatox

    Elranatamab

    Elranatamab

  • Non-small-cell lung cancer

    • Any type of epithelial lung cancer other than small-cell lung carcinoma

    advanced or metastatic SCC. In 2015, FDA also approved the anti-EGFR drug necitumumab for metastatic SCC. In October 2015, the FDA approved pembrolizumab for

    Non-small-cell lung cancer

    Non-small-cell lung cancer

    Non-small-cell_lung_cancer

  • Dehydroepiandrosterone

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Vascular endothelial growth factor

    • Protein involved in blood vessel growth

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • Neurotrophic factors

    • Family of biomolecules

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Neurotrophic factors

    Neurotrophic_factors

  • Insulin

    • Peptide hormone

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Insulin

    Insulin

    Insulin

  • Dihexa

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Dihexa

    Dihexa

    Dihexa

  • IGF-1 LR3

    • Synthetic protein

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    IGF-1 LR3

    IGF-1_LR3

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Fosgonimeton

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fosgonimeton

    Fosgonimeton

    Fosgonimeton

  • Imatinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Imatinib

    Imatinib

    Imatinib

  • Trastuzumab

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • RTK class III

    • Protein family

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    RTK class III

    RTK_class_III

  • Vemurafenib

    • Targeted cancer drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Vemurafenib

    Vemurafenib

    Vemurafenib

  • Amivantamab

    • Monoclonal antibody

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Amivantamab

    Amivantamab

    Amivantamab

  • Filgrastim

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Filgrastim

    Filgrastim

    Filgrastim

  • List of therapeutic monoclonal antibodies

    • osteosarcoma and Ewing sarcoma Nebacumab mab human endotoxin sepsis Necitumumab Portrazza mab human Epidermal growth factor receptor (EGFR) Y non-small

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Tropoflavin

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Tropoflavin

    Tropoflavin

    Tropoflavin

  • ACD856

    • TrkA and TrkB positive modulator

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    ACD856

    ACD856

  • Receptor tyrosine kinase

    • Class of enzymes

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Bevacizumab

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Bevacizumab

    Bevacizumab

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Testosterone (medication)

    • Medication and naturally occurring steroid hormone

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Testosterone (medication)

    Testosterone (medication)

    Testosterone_(medication)

  • Epidermal growth factor receptor

    • Transmembrane protein

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Fibroblast growth factor receptor 3

    • Gene involved in the most common form of dwarfism

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fibroblast growth factor receptor 3

    Fibroblast growth factor receptor 3

    Fibroblast_growth_factor_receptor_3

  • Avapritinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Avapritinib

    Avapritinib

    Avapritinib

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Nerve growth factor

    • Mammalian protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Hepatocyte growth factor

    • Mammalian protein found in Homo sapiens

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Pazopanib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Pazopanib

    Pazopanib

  • Institute for Clinical and Economic Review

    • U.S. nonprofit organization

    preliminary list of drugs to be evaluated includes rociletinib, AZD-9291, necitumumab, nivolumab, and pembrolizumab for small-cell lung cancer; fingolimod

    Institute for Clinical and Economic Review

    Institute_for_Clinical_and_Economic_Review

  • Cabozantinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Cabozantinib

    Cabozantinib

    Cabozantinib

  • Cetuximab

    • Pharmaceutical drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Cetuximab

    Cetuximab

    Cetuximab

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Cerebrolysin

    Cerebrolysin

  • Ranibizumab

    • Pharmaceutical drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Ranibizumab

    Ranibizumab

  • HER2

    • Mammalian protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    HER2

    HER2

    HER2

  • Sorafenib

    • Cancer treatment medicine

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Sorafenib

    Sorafenib

    Sorafenib

  • Axitinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Axitinib

    Axitinib

    Axitinib

  • Insulin-like growth factor

    • Proteins similar to insulin that stimulate cell proliferation

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Insulin-like growth factor

    Insulin-like growth factor

    Insulin-like_growth_factor

  • Lorlatinib

    • Kinase inhibitor for treatment of non-small-cell lung cancer

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Lorlatinib

    Lorlatinib

    Lorlatinib

  • Repotrectinib

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Lenvatinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Infigratinib

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Infigratinib

    Infigratinib

  • Asciminib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Asciminib

    Asciminib

    Asciminib

  • Encorafenib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Encorafenib

    Encorafenib

    Encorafenib

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Dasatinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Dasatinib

    Dasatinib

    Dasatinib

  • Neurotrophin

    • Family of proteins

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Neurotrophin

    Neurotrophin

    Neurotrophin

  • Epidermal growth factor

    • Protein that stimulates cell division and differentiation

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Epidermal growth factor

    Epidermal growth factor

    Epidermal_growth_factor

  • Panitumumab

    • Pharmaceutical drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Panitumumab

    Panitumumab

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Osimertinib

    Osimertinib

    Osimertinib

  • Insulin-like growth factor 1 receptor

    • Cell receptor protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Insulin-like growth factor 1 receptor

    Insulin-like growth factor 1 receptor

    Insulin-like_growth_factor_1_receptor

  • Fibroblast growth factor receptor

    • Family of proteins that bind to fibroblast growth factors

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fibroblast growth factor receptor

    Fibroblast_growth_factor_receptor

  • Fibroblast growth factor

    • Family of proteins involved in anatomical development

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fibroblast growth factor

    Fibroblast_growth_factor

  • KIT gene

    • Mammalian protein and protein-coding gene

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    KIT gene

    KIT gene

    KIT_gene

  • Pertuzumab/trastuzumab/hyaluronidase

    • Combination drug

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Pertuzumab/trastuzumab/hyaluronidase

    Pertuzumab/trastuzumab/hyaluronidase

  • Dabrafenib

    • Anti-cancer medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Dabrafenib

    Dabrafenib

    Dabrafenib

  • Fibroblast growth factor 23

    • Protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Fibroblast growth factor 23

    Fibroblast growth factor 23

    Fibroblast_growth_factor_23

  • Nilotinib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Nilotinib

    Nilotinib

    Nilotinib

  • Platelet-derived growth factor

    • Signaling glycoprotein regulating cell proliferation

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Platelet-derived growth factor

    Platelet-derived growth factor

    Platelet-derived_growth_factor

  • E2511

    • Pharmaceutical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    E2511

    E2511

  • Trastuzumab deruxtecan

    • Medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Hemopoietic growth factor

    • Class of proteins

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Hemopoietic growth factor

    Hemopoietic_growth_factor

  • Sunitinib

    • Cancer medication

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Sunitinib

    Sunitinib

    Sunitinib

  • GDNF family of ligands

    • Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    GDNF family of ligands

    GDNF family of ligands

    GDNF_family_of_ligands

  • Tyrosine kinase

    • Enzyme

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Ponazuril

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Ponazuril

    Ponazuril

    Ponazuril

  • Trk receptor

    • InterPro Family

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Trk receptor

    Trk_receptor

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Integrin

    Integrin

    Integrin

  • Nintedanib

    • Chemical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Nintedanib

    Nintedanib

    Nintedanib

  • Glial cell line-derived neurotrophic factor

    • Protein found in humans

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Glial cell line-derived neurotrophic factor

    Glial cell line-derived neurotrophic factor

    Glial_cell_line-derived_neurotrophic_factor

  • Braegen-02

    • Pharmaceutical compound

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Braegen-02

    Braegen-02

    Braegen-02

  • Erlotinib

    • Medication for treatment of non-small-cell lung cancer

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Erlotinib

    Erlotinib

    Erlotinib

  • Transforming growth factor

    • Biomarker indicative of breast cancer patients' prognosis

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Transforming growth factor

    Transforming_growth_factor

  • Mosunetuzumab

    • Monoclonal antibody

    Mirvetuximab soravtansine Mogamulizumab Moxetumomab pasudotox Naxitamab Necitumumab Nivolumab (+hyaluronidase, +relatlimab) Olaratumab Oportuzumab monatox

    Mosunetuzumab

    Mosunetuzumab

  • Adult neurogenesis

    • Generating of neurons from neural stem cells in adults

    Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none

    Adult neurogenesis

    Adult neurogenesis

    Adult_neurogenesis

AI & ChatGPT searchs for online references containing NECITUMUMAB

NECITUMUMAB

AI search references containing NECITUMUMAB

NECITUMUMAB

AI search queries for Facebook and twitter posts, hashtags with NECITUMUMAB

NECITUMUMAB

Follow users with usernames @NECITUMUMAB or posting hashtags containing #NECITUMUMAB

NECITUMUMAB

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with NECITUMUMAB

NECITUMUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing NECITUMUMAB

NECITUMUMAB

AI searchs for Acronyms & meanings containing NECITUMUMAB

NECITUMUMAB

AI searches, Indeed job searches and job offers containing NECITUMUMAB

Other words and meanings similar to

NECITUMUMAB

AI search in online dictionary sources & meanings containing NECITUMUMAB

NECITUMUMAB